Article info
Original article
Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash
- Correspondence to Tomonori Hirashima, Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, 3-7-1 Habikino, Habikino City, Osaka 583-8588, Japan; hirashimat{at}ra.opho.jp
Citation
Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash
Publication history
- Received April 8, 2016
- Revised June 9, 2016
- Accepted July 6, 2016
- First published August 3, 2016.
Online issue publication
August 29, 2017
Article Versions
- Previous version (3 August 2016).
- Previous version (27 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/